Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EQUITEST

K-Number: K851744 · 1985-08-05

Decision Date1985-08-05
Product CodeLXV
DecisionSubstantially Equivalent

Device Summary

EQUITEST is the device name listed in this FDA 510(k) record. The listed applicant is Neurocom International, Inc.. It received FDA 510(k) clearance on 1985-08-05 under 510(k) number K851744. The device is classified under product code LXV. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EQUITEST?

EQUITEST is a medical device that received FDA 510(k) clearance on 1985-08-05. The listed applicant is Neurocom International, Inc.. The 510(k) number is K851744.

When did EQUITEST receive FDA 510(k) clearance?

EQUITEST received FDA 510(k) clearance on 1985-08-05, under 510(k) number K851744.

Who is the listed applicant for EQUITEST?

The FDA 510(k) record lists Neurocom International, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EQUITEST?

The FDA product code for EQUITEST is LXV.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Neurocom International, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LXV)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑